Showing 181-200 of 374 for: Cochrane Systematic Reviews > Oncology 
- Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy
Cochrane Systematic Reviews, 7-Mar-2011
Oral cavity and oropharyngeal cancers are frequently described as part of a group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally surgery followed by radiotherapy, whereas oropharyngeal cancers, which are more likely
- Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy
Cochrane Systematic Reviews, 9-Nov-2010
The management of advanced oral cavity and oropharyngeal cancers is problematic and has traditionally relied on surgery and radiotherapy, both of which are associated with substantial adverse effects. Radiotherapy has been in use since the 1950s and has t
- Interventions for treating AIDS-associated Hodgkin´s lymphoma in treatment-naive adults
Cochrane Systematic Reviews, 5-Sep-2011
Hodgkin's disease (HD) is the most common non-AIDS-defining malignancy in HIV-infected patients. Its unusually aggressive tumour behaviour includes a higher frequency of unfavourable histologic subtypes, high-stage and extranodal involvement by the time o
- Interventions for treating oral candidiasis for patients with cancer receiving treatment
Cochrane Systematic Reviews, 9-Jun-2010
Treatment of cancer is increasingly effective but is associated with short and long term side effects. Oral and gastrointestinal side effects, including oral candidiasis, remain a major source of illness despite the use of a variety of agents to treat the
- Interventions for treating oral mucositis for patients with cancer receiving treatment
Cochrane Systematic Reviews, 6-Sep-2010
Treatment of cancer is increasingly effective but associated with short and long term side effects. Oral side effects, including oral mucositis (mouth ulceration), remain a major source of illness despite the use of a variety of agents to treat them.
- Interventions targeted at women to encourage the uptake of cervical screening
Cochrane Systematic Reviews, 6-Sep-2021
This is an update of the Cochrane review published in Issue 5, 2011.
- Interventions to enhance return‐to‐work for cancer patients
Cochrane Systematic Reviews, 25-Sep-2015
Cancer patients are 1.4 times more likely to be unemployed than healthy people. Therefore it is important to provide cancer patients with programmes to support the return-to-work (RTW) process. This is an update of a Cochrane review first published in 201
- Interventions to improve continuity of care in the follow-up of patients with cancer
Cochrane Systematic Reviews, 6-Jun-2012
Care from the family physician is generally interrupted when patients with cancer come under the care of second-line and third-line healthcare professionals who may also manage the patient’s comorbid conditions. This situation may lead to fragmented and u
- Interventions to reduce haemorrhage during myomectomy for fibroids
Cochrane Systematic Reviews, 30-Jul-2015
Benign smooth muscle tumours of the uterus, known as fibroids or myomas, are often symptomless. However, about one-third of women with fibroids will present with symptoms that are severe enough to warrant treatment. The standard treatment of symptomatic f
- Intracystic bleomycin for cystic craniopharyngiomas in children
Cochrane Systematic Reviews, 4-Sep-2014
Craniopharyngiomas are the commonest benign histological tumours to involve the hypothalamo-pituitary region in childhood. Cystic craniopharyngiomas comprise more than 90% of the tumours. The optimal treatment of cystic craniopharyngioma remains controver
- Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer
Cochrane Systematic Reviews, 13-Jan-2016
Ovarian cancer tends to be chemosensitive and confine itself to the surface of the peritoneal cavity for much of its natural history. These features have made it an obvious target for intraperitoneal (IP) chemotherapy. Chemotherapy for ovarian cancer is u
- Intravesical Bacillus Calmette-Guérin in Ta and T1 bladder cancer
Cochrane Systematic Reviews, 3-Feb-2010
Intravesical therapy with Bacillus Calmette-Guérin (BCG) aims to reduce the incidence of tumour recurrence following transurethral resection (TUR) for patients with superficial bladder cancer.
- Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer
Cochrane Systematic Reviews, 1-May-2011
Bladder cancer accounts for approximately 4.4% of adult malignancies, and approximately 80% of bladder cancer presents initially as transitional cell carcinoma that is confined to the urothelium (stage Ta) or lamina propria (stage T1). Intravesical admini
- Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
Cochrane Systematic Reviews, 6-Nov-2015
Tumour recurrence following transurethral resection (TUR) for Ta and T1 bladder cancer is a major clinical problem. Intravesical administration of mitomycin C (MMC) or bacillus Calmette-Guérin (BCG) has proven prophylactic activity but both are associated
- Intravesical gemcitabine for non-muscle invasive bladder cancer
Cochrane Systematic Reviews, 1-Dec-2011
Intravesical immunotherapy or chemotherapy for non-muscle invasive bladder cancer is a well established treatment for preventing or delaying tumour recurrence following tumour resection. However, up to 70% of patients may fail and new intravesical agents
- Ketamine as an adjuvant to opioids for cancer pain
Cochrane Systematic Reviews, 16-Oct-2012
This is an update of the original review published in Issue 1, 2003. Ketamine is a commonly used anaesthetic agent, and in subanaesthetic doses is also given as an adjuvant to opioids for the treatment of cancer pain, particularly when opioids alone prove
- Laetrile treatment for cancer
Cochrane Systematic Reviews, 20-Apr-2015
Laetrile is the name for a semi-synthetic compound which is chemically related to amygdalin, a cyanogenic glycoside from the kernels of apricots and various other species of the genus Prunus. Laetrile and amygdalin are promoted under various names for the
- Laparoscopic surgery for presumed benign ovarian tumor during pregnancy
Cochrane Systematic Reviews, 20-Nov-2012
The surgical management of ovarian tumors in pregnancy is similar to that of non-pregnant women. The procedures include resection of the tumor (enucleation), removal of an ovary or ovaries (oophorectomy), or surgical excision of the fallopian tube and ova
- Laparoscopic versus open total mesorectal excision for rectal cancer
Cochrane Systematic Reviews, 7-Apr-2014
Colorectal cancer including rectal cancer is the third most common cause of cancer deaths in the western world. For colon carcinoma, laparoscopic surgery is proven to result in faster postoperative recovery, fewer complications and better cosmetic results
- Laparoscopy versus laparotomy for benign ovarian tumour
Cochrane Systematic Reviews, 20-Sep-2010
Over the last 10 years laparoscopy and minilaparotomy have become increasingly common approaches for the surgical removal of benign ovarian tumours. However, in the event that a tumour is found to be malignant, laparotomy is the appropriate procedure. Car
